VEDT treatment inhibited the EMT induction by enhancing the expression of epithelial marker E-cadherin and decreasing the expression of mesenchymal markers N-cadherin and vimentin in pancreatic cancer cells and in tumor tissues. The gene discussed is CDH1; the disease is familial pancreatic carcinoma.